US FDA explains how to use patient-reported outcomes to support labelling claims
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has issued final guidance explaining how it evaluates patient-reported outcomes to measure treatment benefit in medical product clinical trials1,2.